These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 30909504)

  • 1. Treatment Strategies for Hepatocellular Carcinoma ⁻ a Multidisciplinary Approach.
    Lurje I; Czigany Z; Bednarsch J; Roderburg C; Isfort P; Neumann UP; Lurje G
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update.
    Vivarelli M; Montalti R; Risaliti A
    World J Gastroenterol; 2013 Nov; 19(42):7316-26. PubMed ID: 24259963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curative-Intent Therapies in Localized Hepatocellular Carcinoma.
    O'Leary C; Mahler M; Soulen MC
    Curr Treat Options Oncol; 2020 Mar; 21(4):31. PubMed ID: 32193784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
    Poon RT; Fan ST; Tsang FH; Wong J
    Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment.
    Yegin EG; Oymaci E; Karatay E; Coker A
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):234-56. PubMed ID: 27298100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.
    Fisher RA; Maluf D; Cotterell AH; Stravitz T; Wolfe L; Luketic V; Sterling R; Shiffman M; Posner M
    Clin Transplant; 2004 Oct; 18(5):502-12. PubMed ID: 15344951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Neoadjuvant Transcatheter Arterial Chemoembolization and Orthotopic Liver Transplantation for the Treatment of Cirrhotomimetic Hepatocellular Carcinoma.
    Habibollahi P; Shamchi SP; Tondon R; Ecker BL; Gade TP; Hunt S; Soulen MC; Furth EE; Levine MH; Nadolski G
    J Vasc Interv Radiol; 2018 Feb; 29(2):237-243. PubMed ID: 29221923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical options for hepatocellular carcinoma: resection and transplantation.
    Olthoff KM
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S98-104. PubMed ID: 9742501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: A proposed management algorithm.
    Au KP; Chok KSH
    World J Gastroenterol; 2018 Dec; 24(45):5081-5094. PubMed ID: 30568386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
    Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival.
    Bharat A; Brown DB; Crippin JS; Gould JE; Lowell JA; Shenoy S; Desai NM; Chapman WC
    J Am Coll Surg; 2006 Oct; 203(4):411-20. PubMed ID: 17000383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis.
    Cunningham SC; Tsai S; Marques HP; Mira P; Cameron A; Barroso E; Philosophe B; Pawlik TM
    Ann Surg Oncol; 2009 Jul; 16(7):1820-31. PubMed ID: 19267161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
    El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
    J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatocellular Carcinoma: therapeutic options 2015].
    Schultheiß M; Bettinger D; Neeff HP; Brunner TB; Thimme R
    Dtsch Med Wochenschr; 2015 Jul; 140(14):1063-8. PubMed ID: 26182255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma: current management and recent advances.
    Lau WY; Lai EC
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):237-57. PubMed ID: 18522878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Hepatocellular Carcinoma: Current Status and Future Directions.
    Au JS; Frenette CT
    Gut Liver; 2015 Jul; 9(4):437-48. PubMed ID: 26087860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.
    Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hepatocellular carcinoma.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2003; 3(1):8-24. PubMed ID: 12684589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy.
    Fields TD; Philips P; Scoggins CR; Tatum C; Kelly L; McMasters KM; Martin RCG
    World J Surg; 2017 May; 41(5):1331-1339. PubMed ID: 27905019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.